4-aminophenylethyl-1,4,7,10-tetraazacyclodecane-n,n',n'',n'''-tetraacetic acid and Peritoneal Neoplasms

4-aminophenylethyl-1,4,7,10-tetraazacyclodecane-n,n',n'',n'''-tetraacetic acid has been researched along with Peritoneal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buchsbaum, DJ; Roberson, PL; Rogers, BE; Yokoyama, S	1

Other Studies

1 other study(ies) available for 4-aminophenylethyl-1,4,7,10-tetraazacyclodecane-n,n',n'',n'''-tetraacetic acid and Peritoneal Neoplasms

Article	Year
Three-dimensional dose model for the comparison of 177Lu-HuCC49DeltaCH2 and 177Lu-HuCC49 radioimunotherapy in mice bearing intraperitoneal xenografts. Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:2 Topics: Aniline Compounds; Animals; Antibodies, Monoclonal; Colonic Neoplasms; Dose-Response Relationship, Radiation; Heterocyclic Compounds; Humans; Lutetium; Mice; Mice, Nude; Models, Biological; Neoplasms, Experimental; Peritoneal Neoplasms; Radioimmunotherapy; Radiotherapy Dosage; Tissue Distribution; Transplantation, Heterologous	2003

Article

Year

Three-dimensional dose model for the comparison of 177Lu-HuCC49DeltaCH2 and 177Lu-HuCC49 radioimunotherapy in mice bearing intraperitoneal xenografts.

Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:2

Topics: Aniline Compounds; Animals; Antibodies, Monoclonal; Colonic Neoplasms; Dose-Response Relationship, Radiation; Heterocyclic Compounds; Humans; Lutetium; Mice; Mice, Nude; Models, Biological; Neoplasms, Experimental; Peritoneal Neoplasms; Radioimmunotherapy; Radiotherapy Dosage; Tissue Distribution; Transplantation, Heterologous

2003